Dr. Reddy's Laboratories Limited — Others, 24-07-2025: Shareholders meeting

Dr. Reddy's Laboratories' 41st Annual General Meeting saw shareholders approve all proposed resolutions. Key approvals included the adoption of the Audited Financial Statements for FY2025 and the declaration of a dividend of Rs. 8 per equity share. Shareholders also endorsed the re-appointment of Mr. G V Prasad as Director and as Co-Chairman and Managing Director. Additionally, the appointment of Cost Auditors and Secretarial Auditors for the upcoming financial year was approved. The strong voting results indicate robust shareholder support for the company's governance and strategic direction.